ArticleJournal of renal injury prevention2013
Serum lipoprotein (a) and atherosclerotic changes in hemodialysis patients.
Article in Journal of renal injury prevention, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Herbal versus synthetic drugs; beliefs and facts.Journal of nephropharmacology · 2015Review
- On the occasion of world hypertension day 2014: A nephrology point of view.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2014Article
- Atherosclerosis: process, indicators, risk factors and new hopes.International journal of preventive medicine · 2014Review
- Anethum graveolens and hyperlipidemia: A randomized clinical trial.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2014Article
- Oxidative stress and hypertension: Possibility of hypertension therapy with antioxidants.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2014Review
- Oxidative stress and aging prevention.International journal of preventive medicine · 2013Article
- Medicinal Plants and New Concerns in Statin Consumption.Iranian journal of public health · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionLipoprotein (a) [Lp(a)] is considered as a risk factor for coronary atherosclerotic disorder and an increase in plasma Lp(a) concentration is usually seen in patients with kidney failure.
objectivesWe aimed in this study to evaluate the impact of plasma Lp(a) level on early changes of atherosclerotic vessels in stable hemodialysis (HD) patients. PATIENTS AND
methodsIn this clinical study 61 patients (50 non-diabetic (F=20 M=30) and 11 diabetic HD patients), receiving maintenance hemodialysis were included and serum Lp(a) was measured. B-mode ultrasonography of carotid intima-media thickness (cIMT) was also determined.
resultsThe mean ±SD of patients Lp(a) was 58.5±19 mg/dL. The mean ±SD of diabetic patients' Lp(a) was 62±12mg/dL and for nondiabetic ones was 57.7± 20mg/dL. In this study the thickening of Intima-media complex in diabetic group was more than non-diabetics, and no significant difference was found of Lp(a) between diabetic and non diabetic HD patients. There was a significant positive association between serum Lp(a) and cIMT.
conclusionAccelerated atherosclerosis seen in diabetic hemodialysis patients. Lp(a) might have an important role in progression of atherosclerosis to accelerate progressive atherosclerosis in these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.